德生科技(002908.SZ):兩名董事提前終止減持計劃 劉峻峯已減持112.86萬股
格隆匯4月23日丨德生科技(002908.SZ)公佈,近日,公司收到了董事劉峻峯和李竹的書面辭職報告。劉峻峯、李竹因個人原因申請辭去公司第二屆董事會非獨立董事職務。辭去董事職務後,劉峻峯、李竹不再擔任公司任何其他職務。因此,上述兩名董事的減持計劃提前終止,劉峻峯累計減持112.86萬股,佔公司總股本0.5619%。此次減持後,劉峻峯持有股份815.7萬股,佔總股本比例4.06%。
在此期間,李竹先生未減持公司股份,截止目前,李竹先生持有公司351.8萬股股份,佔公司股份總數的1.75%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.